AZD8529 Single Ascending Dose Study

NCT00755378 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: AZD8529
DRUG: Placebo

Sponsor

AstraZeneca